NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the 20 th Annual Needham Virtual Healthcare Conference on April 13 th at 12:45 pm Eastern time. A live audio webcast will be available through the Investors section of the company’s website at www
April 7, 2021
· 2 min read